US Patent Issued to The Trustees of the University of Pennsylvania, Novartis on June 16 for "Combination therapy using a chimeric antigen receptor" (American, Finnish Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,850, issued on June 16, was assigned to The Trustees of the University of Pennsylvania (Philadelphia) and Novartis AG (Basel, Switzerland).

"Combination therapy using a chimeric antigen receptor" was invented by Carl H. June (Merion Station, Pa.), Keisuke Watanabe (Wynnewood, Pa.), Sonia Guedan Carrio (Philadelphia), Akseli Hemminki (Helsinki), John Scholler (Narbeth, Pa.) and Regina M. Young (Bryn Mawr, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides compositions and methods for treating diseases such as cancer. The invention also relates to a method of administering a chimeric antigen receptor (CAR) therapy and an additio...